First application of genetically modified, live-cell, pig skin to a human wound

Burn specialists at Massachusetts General Hospital (MGH) announced today they have successfully used live-cell, genetically engineered pig skin (xenograft) for the temporary closure of a burn wound. Through an FDA-cleared phase one clinical trial led by surgeon Jeremy Goverman, MD, of the MGH Sumner Redstone Burn Service, this procedure marks the first-time pig tissue derived from an animal with gene edits has been transplanted directly onto a human wound.

From http://besthealthnews.com/2019/10/first-application-of-genetically-modified-live-cell-pig-skin-to-a-human-wound/?utm_source=rss&utm_medium=rss&utm_campaign=first-application-of-genetically-modified-live-cell-pig-skin-to-a-human-wound

from
https://healthnews010.wordpress.com/2019/10/12/first-application-of-genetically-modified-live-cell-pig-skin-to-a-human-wound/